Are peptides
legal?
Independent, regularly updated guides to research peptide legality across five markets. Compound-specific scheduling status, FAQ and regulatory context.
By market
Select your market
Are peptides legal in Australia?
Most research peptides are unscheduled under TGA guidelines. BPC-157, retatrutide and GH peptides are legal for research. GLP-1 medicines require a prescription.
Read full guide →Are peptides legal in the UK?
Research peptides are not controlled under the Misuse of Drugs Act. Most compounds are legal to purchase for research. Licensed GLP-1 medicines require a prescription.
Read full guide →Are peptides legal in Canada?
Most research peptides are not scheduled under Canadian drug scheduling. Legal to import for research purposes. DIN-listed medicines require a prescription.
Read full guide →Sind Peptide legal in Deutschland?
Die meisten Forschungspeptide sind in Deutschland nicht klassifiziert und können für Forschungszwecke erworben werden. Zugelassene GLP-1-Arzneimittel sind verschreibungspflichtig.
Read full guide →Are peptides legal in the US?
Research peptides not scheduled by the DEA are legal for laboratory research. The FDA has increased scrutiny of peptides sold for human consumption. Approved medicines require a prescription.
Read full guide →About this guide
How we approach regulatory information
Peptide Library provides independent, evidence-based information on research peptides. Our regulatory guides are maintained by reviewing current scheduling lists, TGA/MHRA/Health Canada/BfArM/FDA publications, and legal precedent in each market.
Regulatory status changes. Compounds can be rescheduled, new approved medicines can change the landscape, and enforcement approaches vary. We recommend verifying current status directly with the relevant regulatory body before purchasing.
This information is for educational purposes only and does not constitute legal advice. For legal advice regarding a specific situation, consult a qualified legal professional in your jurisdiction.